S&P 500   4,303.57 (+0.22%)
DOW   33,879.88 (+0.14%)
QQQ   354.86 (+0.48%)
AAPL   181.84 (+0.70%)
MSFT   327.35 (+0.64%)
META   264.42 (-0.06%)
GOOGL   122.76 (+0.51%)
AMZN   123.96 (-0.23%)
TSLA   245.08 (+4.35%)
NVDA   388.50 (+0.88%)
NIO   7.79 (+0.00%)
BABA   85.67 (-0.55%)
AMD   124.61 (+2.94%)
T   16.00 (-0.44%)
F   13.72 (+1.03%)
MU   65.17 (-0.23%)
CGC   0.67 (-3.88%)
GE   105.92 (-0.14%)
DIS   91.78 (-0.81%)
AMC   4.73 (+1.07%)
PFE   38.97 (-0.31%)
PYPL   63.52 (-1.12%)
NFLX   421.00 (+2.84%)
S&P 500   4,303.57 (+0.22%)
DOW   33,879.88 (+0.14%)
QQQ   354.86 (+0.48%)
AAPL   181.84 (+0.70%)
MSFT   327.35 (+0.64%)
META   264.42 (-0.06%)
GOOGL   122.76 (+0.51%)
AMZN   123.96 (-0.23%)
TSLA   245.08 (+4.35%)
NVDA   388.50 (+0.88%)
NIO   7.79 (+0.00%)
BABA   85.67 (-0.55%)
AMD   124.61 (+2.94%)
T   16.00 (-0.44%)
F   13.72 (+1.03%)
MU   65.17 (-0.23%)
CGC   0.67 (-3.88%)
GE   105.92 (-0.14%)
DIS   91.78 (-0.81%)
AMC   4.73 (+1.07%)
PFE   38.97 (-0.31%)
PYPL   63.52 (-1.12%)
NFLX   421.00 (+2.84%)
S&P 500   4,303.57 (+0.22%)
DOW   33,879.88 (+0.14%)
QQQ   354.86 (+0.48%)
AAPL   181.84 (+0.70%)
MSFT   327.35 (+0.64%)
META   264.42 (-0.06%)
GOOGL   122.76 (+0.51%)
AMZN   123.96 (-0.23%)
TSLA   245.08 (+4.35%)
NVDA   388.50 (+0.88%)
NIO   7.79 (+0.00%)
BABA   85.67 (-0.55%)
AMD   124.61 (+2.94%)
T   16.00 (-0.44%)
F   13.72 (+1.03%)
MU   65.17 (-0.23%)
CGC   0.67 (-3.88%)
GE   105.92 (-0.14%)
DIS   91.78 (-0.81%)
AMC   4.73 (+1.07%)
PFE   38.97 (-0.31%)
PYPL   63.52 (-1.12%)
NFLX   421.00 (+2.84%)
S&P 500   4,303.57 (+0.22%)
DOW   33,879.88 (+0.14%)
QQQ   354.86 (+0.48%)
AAPL   181.84 (+0.70%)
MSFT   327.35 (+0.64%)
META   264.42 (-0.06%)
GOOGL   122.76 (+0.51%)
AMZN   123.96 (-0.23%)
TSLA   245.08 (+4.35%)
NVDA   388.50 (+0.88%)
NIO   7.79 (+0.00%)
BABA   85.67 (-0.55%)
AMD   124.61 (+2.94%)
T   16.00 (-0.44%)
F   13.72 (+1.03%)
MU   65.17 (-0.23%)
CGC   0.67 (-3.88%)
GE   105.92 (-0.14%)
DIS   91.78 (-0.81%)
AMC   4.73 (+1.07%)
PFE   38.97 (-0.31%)
PYPL   63.52 (-1.12%)
NFLX   421.00 (+2.84%)
NASDAQ:SMTI

Sanara MedTech (SMTI) Stock Forecast, Price & News

$39.93
+0.06 (+0.15%)
(As of 01:05 PM ET)
Compare
Today's Range
$39.93
$40.77
50-Day Range
$33.54
$49.68
52-Week Range
$18.89
$50.18
Volume
3,964 shs
Average Volume
15,265 shs
Market Capitalization
$334.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.00

SMTI stock logo

About Sanara MedTech (NASDAQ:SMTI) Stock

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

Receive SMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanara MedTech and its competitors with MarketBeat's FREE daily newsletter.

SMTI Stock News Headlines

Graphite versus Lithium - What Investors Should Know
Over 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.
Sanara MedTech: Q1 Earnings Insights
Graphite versus Lithium - What Investors Should Know
Over 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.
Earnings Outlook For Sanara MedTech
See More Headlines

SMTI Price History

SMTI Company Calendar

Last Earnings
3/20/2023
Today
6/09/2023
Next Earnings (Estimated)
8/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SMTI
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$50.00
High Stock Price Forecast
$50.00
Low Stock Price Forecast
$50.00
Forecasted Upside/Downside
+23.4%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-7,940,000.00
Pretax Margin
-22.40%

Debt

Sales & Book Value

Annual Sales
$53.55 million
Book Value
$5.02 per share

Miscellaneous

Free Float
3,756,000
Market Cap
$339.68 million
Optionable
Not Optionable
Beta
1.82

Key Executives

  • Zach Fleming
    Chief Executive Officer
  • Callon Nichols
    Vice President-Corporate Operations
  • Michael D. McNeil
    Chief Financial Officer & Secretary
  • Rebecca E. McMahon
    President-Research & Development
  • Prodromos Ververeli
    Vice President-Medical Affairs













SMTI Stock - Frequently Asked Questions

What is Sanara MedTech's stock price forecast for 2023?

0 Wall Street research analysts have issued 1 year price objectives for Sanara MedTech's shares. Their SMTI share price forecasts range from $50.00 to $50.00. On average, they anticipate the company's stock price to reach $50.00 in the next twelve months. This suggests a possible upside of 23.4% from the stock's current price.
View analysts price targets for SMTI
or view top-rated stocks among Wall Street analysts.

How have SMTI shares performed in 2023?

Sanara MedTech's stock was trading at $45.50 on January 1st, 2023. Since then, SMTI shares have decreased by 10.9% and is now trading at $40.52.
View the best growth stocks for 2023 here
.

Are investors shorting Sanara MedTech?

Sanara MedTech saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 62,900 shares, a drop of 14.0% from the April 30th total of 73,100 shares. Based on an average daily trading volume, of 18,200 shares, the short-interest ratio is presently 3.5 days. Currently, 1.9% of the company's stock are sold short.
View Sanara MedTech's Short Interest
.

When is Sanara MedTech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023.
View our SMTI earnings forecast
.

How were Sanara MedTech's earnings last quarter?

Sanara MedTech Inc. (NASDAQ:SMTI) posted its earnings results on Monday, March, 20th. The company reported ($0.51) EPS for the quarter. The company earned $15.32 million during the quarter. Sanara MedTech had a negative net margin of 18.67% and a negative trailing twelve-month return on equity of 25.60%.

What other stocks do shareholders of Sanara MedTech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanara MedTech investors own include Lakeland Industries (LAKE), Ovintiv (OVV), SIG (SHI), Zynerba Pharmaceuticals (ZYNE), AbbVie (ABBV), American Airlines Group (AAL), Abbott Laboratories (ABT), Aurora Cannabis (ACB), AC Immune (ACIU) and Applied Genetic Technologies (AGTC).

What is Sanara MedTech's stock symbol?

Sanara MedTech trades on the NASDAQ under the ticker symbol "SMTI."

Who are Sanara MedTech's major shareholders?

Sanara MedTech's stock is owned by a variety of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (0.35%), Susquehanna International Group LLP (0.30%), Ameriprise Financial Inc. (0.21%), Jane Street Group LLC (0.21%), HRT Financial LP (0.13%) and State Street Corp (0.12%). Insiders that own company stock include Shawn M Bowman and Zachary B Fleming.
View institutional ownership trends
.

How do I buy shares of Sanara MedTech?

Shares of SMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sanara MedTech's stock price today?

One share of SMTI stock can currently be purchased for approximately $40.52.

How much money does Sanara MedTech make?

Sanara MedTech (NASDAQ:SMTI) has a market capitalization of $339.68 million and generates $53.55 million in revenue each year. The company earns $-7,940,000.00 in net income (profit) each year or ($1.25) on an earnings per share basis.

How can I contact Sanara MedTech?

Sanara MedTech's mailing address is 1200 Summit Avenue Suite 414, Fort Worth TX, 76102. The official website for the company is www.wndm.com. The company can be reached via phone at (817) 529-2300 or via email at ir@sanaramedtech.com.

This page (NASDAQ:SMTI) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -